Nuvectis Pharma Q4 EPS $(0.31), Inline

Nuvectis Pharma, Inc. -0.88%

Nuvectis Pharma, Inc.

NVCT

8.96

-0.88%

Nuvectis Pharma (NASDAQ: NVCT) reported quarterly losses of $(0.31) per share which met the analyst consensus estimate. This is a 13.89 percent increase over losses of $(0.36) per share from the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via